Literature DB >> 12325053

Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men.

E Hogervorst1, D J Lehmann, D R Warden, J McBroom, A D Smith.   

Abstract

OBJECTIVES: To assess the association between testosterone levels and APOEepsilon4 in cases with AD and controls.
METHOD: We included 61 men with definite or probable Alzheimer's disease (AD) and 55 elderly male controls from the Oxford Project to Investigate Memory and Ageing (OPTIMA). Testosterone was measured using a competitive enzyme immunoassay (Bayer).
RESULTS: We found that both low serum testosterone and the interaction between testosterone and APOEepsilon4 were associated with AD. Furthermore, testosterone levels were lower in APOEepsilon4-positive controls (mean: 11.3 nmol/L) than in controls without the allele (19.1 nmol/L).
CONCLUSIONS: Low testosterone is potentially a modifiable risk factor, which may prove relevant to APOEepsilon4 carriers who are at risk of AD. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12325053     DOI: 10.1002/gps.714

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  19 in total

1.  Castration in rats impairs performance during acquisition of a working memory task and exacerbates deficits in working memory produced by scopolamine and mecamylamine.

Authors:  Jill M Daniel; Peter J Winsauer; Joseph M Moerschbaecher
Journal:  Psychopharmacology (Berl)       Date:  2003-07-25       Impact factor: 4.530

Review 2.  Androgens, aging, and Alzheimer's disease.

Authors:  Christian J Pike; Emily R Rosario; Thuy-Vi V Nguyen
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 3.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

Review 4.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

5.  Genetic influences on hippocampal volume differ as a function of testosterone level in middle-aged men.

Authors:  Matthew S Panizzon; Richard L Hauger; Lindon J Eaves; Chi-Hua Chen; Anders M Dale; Lisa T Eyler; Bruce Fischl; Christine Fennema-Notestine; Carol E Franz; Michael D Grant; Kristen C Jacobson; Amy J Jak; Michael J Lyons; Sally P Mendoza; Michael C Neale; Elizabeth Prom-Wormley; Larry J Seidman; Ming T Tsuang; Hong Xian; William S Kremen
Journal:  Neuroimage       Date:  2011-10-01       Impact factor: 6.556

Review 6.  Neuroanatomical and molecular correlates of cognitive and behavioural outcomes in hypogonadal males.

Authors:  O B Akinola; M O Gabriel
Journal:  Metab Brain Dis       Date:  2017-12-11       Impact factor: 3.584

7.  Testosterone modifies the effect of APOE genotype on hippocampal volume in middle-aged men.

Authors:  M S Panizzon; R Hauger; A M Dale; L J Eaves; L T Eyler; B Fischl; C Fennema-Notestine; C E Franz; M D Grant; A J Jak; K C Jacobson; M J Lyons; S P Mendoza; M C Neale; E C Prom-Wormley; L J Seidman; M T Tsuang; H Xian; W S Kremen
Journal:  Neurology       Date:  2010-09-07       Impact factor: 9.910

Review 8.  Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions.

Authors:  Anusha Jayaraman; Christian J Pike
Journal:  Curr Diab Rep       Date:  2014-04       Impact factor: 4.810

Review 9.  Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

Authors:  Mariana F Uchoa; V Alexandra Moser; Christian J Pike
Journal:  Front Neuroendocrinol       Date:  2016-09-17       Impact factor: 8.606

Review 10.  Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease.

Authors:  Emily R Rosario; Christian J Pike
Journal:  Brain Res Rev       Date:  2007-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.